Literature DB >> 15545984

IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.

Anne O'Garra1, Pedro L Vieira, Paulo Vieira, Anne E Goldfeld.   

Abstract

Effective immune responses against pathogens are sometimes accompanied by strong inflammatory reactions. To minimize damage to self, the activation of the immune system also triggers anti-inflammatory circuits. Both inflammatory and anti-inflammatory reactions are normal components of the same immune response, which coordinately fight infections while preventing immune pathology. IL-10 is an important suppressive cytokine, produced by a large number of immune cells in addition to the antigen-driven IL-10-producing regulatory and the naturally occurring suppressor CD4+ T cells, which is a key player in anti-inflammatory immune responses. However, additional mechanisms have evolved to ensure that pathogen eradication is achieved with minimum damage to the host. Here we discuss those mechanisms that operate to regulate effector immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545984      PMCID: PMC525746          DOI: 10.1172/JCI23215

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  104 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.

Authors:  Anette Sundstedt; Emma J O'Neill; Kirsty S Nicolson; David C Wraith
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

3.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

4.  CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice.

Authors:  Damo Xu; Haiying Liu; Mousa Komai-Koma; Carol Campbell; Charlie McSharry; James Alexander; Foo Y Liew
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

5.  In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions.

Authors:  Gael Fenhalls; Liesel Stevens; Lorraine Moses; Juanita Bezuidenhout; Joanna C Betts; Paul van Helden Pv; Pauline T Lukey; Ken Duncan
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.

Authors:  Henry W Murray; Christina M Lu; Smita Mauze; Sherry Freeman; Andre L Moreira; Gilla Kaplan; Robert L Coffman
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism.

Authors:  Takatoku Oida; Xingmin Zhang; Masao Goto; Satoshi Hachimura; Mamoru Totsuka; Shuichi Kaminogawa; Howard L Weiner
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

8.  Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.

Authors:  Alexander D Edwards; Shivanthi P Manickasingham; Roman Spörri; Sandra S Diebold; Oliver Schulz; Alan Sher; Tsuneyasu Kaisho; Shizuo Akira; Caetano Reis e Sousa
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

9.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  188 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Authors:  Qiaoling Liang; Lei Guo; Shaila Gogate; Zunayet Karim; Arezoo Hanifi; Donald Y Leung; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 3.  Immunoregulation in TB: observations and implications.

Authors:  Jerrold J Ellner
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

4.  Autoimmunity: Antigen-specific immunotherapy.

Authors:  David Wraith
Journal:  Nature       Date:  2016-02-17       Impact factor: 49.962

Review 5.  An integrated view of suppressor T cell subsets in immunoregulation.

Authors:  Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production.

Authors:  Laura Conejero; Sofía C Khouili; Sarai Martínez-Cano; Helena M Izquierdo; Paola Brandi; David Sancho
Journal:  JCI Insight       Date:  2017-05-18

7.  Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.

Authors:  A Singh; A Mohan; A B Dey; D K Mitra
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

8.  Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis.

Authors:  Saurav Brahmachari; Kalipada Pahan
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 9.  Role of endogenous and induced regulatory T cells during infections.

Authors:  Elizabeth Wohlfert; Yasmine Belkaid
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

10.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.